Insufficient scRNA-seq data for expression of SCN4B at single-cell level.
Insufficient scRNA-seq data for expression of SCN4B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 8339.71 | 2458 / 2642 | 99% | 35.91 | 700 / 705 |
thymus | 99% | 4512.58 | 649 / 653 | 90% | 26.57 | 544 / 605 |
breast | 90% | 2865.65 | 415 / 459 | 71% | 5.45 | 794 / 1118 |
prostate | 83% | 1156.36 | 204 / 245 | 72% | 3.10 | 363 / 502 |
lung | 84% | 1981.72 | 484 / 578 | 55% | 3.36 | 636 / 1155 |
adrenal gland | 48% | 758.96 | 123 / 258 | 69% | 6.41 | 158 / 230 |
esophagus | 64% | 1120.27 | 931 / 1445 | 41% | 2.35 | 75 / 183 |
kidney | 26% | 300.71 | 23 / 89 | 72% | 15.01 | 649 / 901 |
pancreas | 11% | 104.30 | 37 / 328 | 82% | 5.55 | 146 / 178 |
adipose | 87% | 2798.79 | 1053 / 1204 | 0% | 0 | 0 / 0 |
heart | 87% | 1927.59 | 753 / 861 | 0% | 0 | 0 / 0 |
skin | 32% | 384.46 | 582 / 1809 | 53% | 5.35 | 249 / 472 |
muscle | 84% | 1506.08 | 673 / 803 | 0% | 0 | 0 / 0 |
uterus | 47% | 616.60 | 80 / 170 | 25% | 1.91 | 117 / 459 |
intestine | 43% | 539.05 | 419 / 966 | 17% | 0.84 | 92 / 527 |
bladder | 33% | 580.67 | 7 / 21 | 23% | 1.18 | 115 / 504 |
stomach | 25% | 260.75 | 91 / 359 | 23% | 1.28 | 65 / 286 |
ovary | 5% | 89.14 | 9 / 180 | 24% | 1.12 | 105 / 430 |
blood vessel | 26% | 343.33 | 350 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 1.50 | 20 / 80 |
tonsil | 0% | 0 | 0 / 0 | 24% | 0.95 | 11 / 45 |
liver | 1% | 7.21 | 2 / 226 | 18% | 0.61 | 74 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0086012 | Biological process | membrane depolarization during cardiac muscle cell action potential |
GO_2000649 | Biological process | regulation of sodium ion transmembrane transporter activity |
GO_0060307 | Biological process | regulation of ventricular cardiac muscle cell membrane repolarization |
GO_0086002 | Biological process | cardiac muscle cell action potential involved in contraction |
GO_0086016 | Biological process | AV node cell action potential |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0010765 | Biological process | positive regulation of sodium ion transport |
GO_0006814 | Biological process | sodium ion transport |
GO_0019228 | Biological process | neuronal action potential |
GO_0086091 | Biological process | regulation of heart rate by cardiac conduction |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0001518 | Cellular component | voltage-gated sodium channel complex |
GO_0014704 | Cellular component | intercalated disc |
GO_0086006 | Molecular function | voltage-gated sodium channel activity involved in cardiac muscle cell action potential |
GO_0005248 | Molecular function | voltage-gated sodium channel activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0017080 | Molecular function | sodium channel regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SCN4B |
Protein name | Sodium channel subunit beta-4 Sodium channel beta-4 subunit (Sodium channel, voltage-gated, type IV, beta, isoform CRA_b) (cDNA, FLJ95353, Homo sapiens sodium channel, voltage-gated, type IV, beta (SCN4B),mRNA) |
Synonyms | hCG_1646677 |
Description | FUNCTION: Modulates channel gating kinetics. Causes negative shifts in the voltage dependence of activation of certain alpha sodium channels, but does not affect the voltage dependence of inactivation. Modulates the susceptibility of the sodium channel to inhibition by toxic peptides from spider, scorpion, wasp and sea anemone venom. . |
Accessions | ENST00000324727.9 [Q8IWT1-1] B0YJ93 Q8IWT1 ENST00000529878.1 [Q8IWT1-3] |